Exact Mass: 329.0222
Exact Mass Matches: 329.0222
Found 36 metabolites which its exact mass value is equals to given mass value 329.0222,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fentiazac
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
FENTIAZAC
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1-CYCLOPENTYL-3-IODO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE
8-Bromo-2-deoxyadenosine
8-Bromo-2'-deoxyadenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
2-[2-(2-chlorophenyl)-4-phenyl-1,3-thiazol-5-yl]acetic acid
3-AMINO-7-BROMO-5-PHENYL-1,3-DIHYDRO-BENZO[E][1,4]DIAZEPIN-2-ONE
3-(4,6-DICHLORO-2-(ETHOXYCARBONYL)-1H-INDOL-3-YL)PROPANOICACID
N-(tert-Butoxycarbonyl)-3-iodo-L-alanine Methyl Ester
N-(4-Bromophenyl)-N-{[(2-methyl-2-propanyl)oxy]carbonyl}glycine
5,6-dichloro-2-[4-(2H-tetrazol-5-yl)phenyl]-1H-indole
2-[2-(4-CHLOROPHENYL)-4-PHENYL-1,3-THIAZOL-5-YL]ACETIC ACID
(S)-2-(2-Bromophenyl)-2-((tert-butoxycarbonyl)amino)acetic acid
(2R)-2-[(TERT-BUTOXY)CARBONYLAMINO]-2-(4-BROMOPHENYL)ACETIC ACID
2-{[4-(Trifluoromethoxy)benzoyl]amino}ethyl Dihydrogen Phosphate
2-(6-Imidazo[2,1-b]thiazolyl)acetic acid 1,3-benzothiazol-2-ylmethyl ester
1-[2-[(2,5-dichlorophenyl)thio]-4-fluorophenyl]-N,N-dimethylmethanamine
3,5-cyclic IMP(1-)
An organophosphate oxoanion that is the conjugate base of 3,5-cyclic IMP arising from deprotonation of the free phosphate OH group; major species at pH 7.3.
